Global  

BAT says potential COVID-19 vaccine using tobacco leaves ready for human trials

Reuters Friday, 15 May 2020
World's No.2 cigarette company British American Tobacco said on Friday it was ready to test its potential COVID-19 vaccine using proteins from tobacco leaves on humans, after it generated a positive immune response in pre-clinical trials.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Volunteers sign up for potential COVID-19 trial [Video]

Volunteers sign up for potential COVID-19 trial

Volunteers sign up for potential COVID-19 trial

Credit: ABC 10 News | San Diego     Duration: 02:21Published
Covid vaccine race| India puts 2 to human trials: Where do we stand? |Oneindia News [Video]

Covid vaccine race| India puts 2 to human trials: Where do we stand? |Oneindia News

India's Covaxin has entered clinical trials while the Drug controller Genral of India gave the nod for another vaccine by Zydus Cadila for phase I and II human trials. ICMR has asked Bharat Biotech to..

Credit: Oneindia     Duration: 01:30Published
Covid vaccine race| India puts 2 to human trials: Where do we stand? | Oneindia News [Video]

Covid vaccine race| India puts 2 to human trials: Where do we stand? | Oneindia News

India's Covaxin has entered clinical trials while the Drug controller Genral of India gave the nod for another vaccine by Zydus Cadila for phase I and II human trials. ICMR has asked Bharat Biotech to..

Credit: Oneindia     Duration: 02:34Published

Tweets about this

PragmatistProf

Debbie Seltzer This says it all about our medical system. A potential COVID 19 vaccine was financed by our tax dollars, then the p… https://t.co/Pu9PJmLg0N 1 day ago

ALBusinessNews

AlabamaBusinessNews RT @ALReporter: Si02 will be able to produce the needed supply of vials so that the vaccine, once developed and approved for widespread use… 2 days ago

HackMaruko

Hack Maruko RT @NewsBFM: Johnson & Johnson says it will begin its human trial for a potential Covid-19 vaccine in the second half of July, two months e… 2 days ago

damidefelice

Damiano de Felice What's the ROI on a #COVID19 vaccine? Pfizer Chief Business Officer: We are well aware of the need to balance the… https://t.co/zujO8fnMib 2 days ago

ALReporter

Alabama Political Reporter Si02 will be able to produce the needed supply of vials so that the vaccine, once developed and approved for widesp… https://t.co/Gr2hX2st3w 2 days ago

NewsBFM

BFM News Johnson & Johnson says it will begin its human trial for a potential Covid-19 vaccine in the second half of July, t… https://t.co/LHwMIToqmV 3 days ago

DivyaRsr

Divya Renganathan RT @sachinr27: Indian firm Panacea Biotec says aiming to make 500 million doses of a potential COVID-19 vaccine https://t.co/6Nf7yQFpO0 3 days ago

Scimitar_SS

ScImItar ⚔️ @RedInkWisdom @Rita_Banerji @itsstillneha Seems she's counting on ya'll to get educated to make u receptive to vacc… https://t.co/yW3122JNw3 3 days ago